Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

American Cryostem Corp (OP: CRYO )

N/A UNCHANGED
Last Price Updated: 3:04 PM EDT, Apr 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about American Cryostem Corp

American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
EATONTOWN, NJ / ACCESSWIRE / March 4, 2022 / American CryoStem Corporation (OTC PINK:CRYO) a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and... 
From American CryoStem Corporation
Via AccessWire
American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing... 
From American CryoStem Corporation
Via AccessWire
American CryoStem Completes Clinical Protocol Design for Long COVID Study
EATONTOWN, NJ / ACCESSWIRE / November 30, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies today announced... 
From American CryoStem Corporation
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board
EATONTOWN, NJ / ACCESSWIRE / November 23, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose tissue-based cellular technologies for... 
From American CryoStem Corporation
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
American CryoStem to Study New Standardized Treatment Protocols for Wound Healing
EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing... 
From American CryoStem Corporation
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
American CryoStem Enters into an Agreement to Exchange Shares held by ACS Global, Inc
EATONTOWN, NJ / ACCESSWIRE / November 12, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading strategic cellular application developer, global licensor of patented adipose tissue-based... 
From American CryoStem Corporation
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study
EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and... 
From American CryoStem Corporation
Via AccessWire
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.